Pegunigalsidase alfa (ELFABRIO)

Enzyme replacement therapy (pegylated recombinant alpha-galactosidase A)

Pegunigalsidase alfa (ELFABRIO)

Forms and strengths
Form: TabletStrength: 2 mg/mL
Print

Indication

  • Pegunigalsidase alfa is used for the long-term treatment of adults with a confirmed diagnosis of Fabry disease (alpha-galactosidase A deficiency).

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.